MEKK1 regulates the AP-1 dimer repertoire via control of JunB transcription and Fra-2 protein stability

被引:30
作者
Cuevas, BD
Uhlik, MT
Garrington, TP
Johnson, GL
机构
[1] Univ N Carolina, Sch Med, Dept Pharmacol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[2] Univ Colorado, Hlth Sci Ctr, Sch Med, Dept Pediat, Denver, CO 80262 USA
关键词
MEKK1; AP-1; dimer;
D O I
10.1038/sj.onc.1208239
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activator protein 1 (AP-1) transcription factor dimers are composed of Jun, Fos, and ATF member proteins, but the mechanisms that determine AP-1 composition are not clearly de. ned and the function of specific dimers is not well understood. MEKK1 is a mitogen-activated protein kinase ( MAPK) kinase kinase and an ubiquitin ligase that regulates both the extracellular signal-regulated kinase 1/2 and the c-Jun amino-terminal kinase. Herein, we demonstrate that MEKK1 regulates the AP-1 protein repertoire. Both FGF-2 and phorbol ester-inducible urokinase-type plasminogen activator (uPA) expression requires AP-1 binding to an enhancer element in the uPA promoter, and we have previously shown that FGF-2 or PMA induction of uPA expression is strongly dependent on MEKK1. JunB mRNA is significantly increased in MEKK1-/- cells, demonstrating that MEKK1 suppresses JunB mRNA expression. Upregulation of JunB expression in MEKK1-/- cells forms an inhibitory AP-1 complex that binds to the uPA promoter and inhibits uPA transcription. MEKK1 also regulates Fra-2 protein stability by inducing Fra-2 ubiquitination and degradation. MEKK1 regulates AP-1-dependent gene expression by regulating the expression, activity and degradation of component members of the AP-1 complex. Controlling the repertoire of a transcription factor complex is a newly defined function for an MAPK kinase kinase.
引用
收藏
页码:801 / 809
页数:9
相关论文
共 47 条
[1]   Multiple degradation pathways for Fos family proteins [J].
Acquaviva, C ;
Bossis, G ;
Ferrara, P ;
Brockly, F ;
Jariel-Encontre, I ;
Piechaczyk, M .
CELL SIGNALING, TRANSCRIPTION, AND TRANSLATION AS THERAPEUTIC TARGETS, 2002, 973 :426-434
[2]   Degradation of cellular and viral Fos proteins [J].
Acquaviva, C ;
Ferrara, P ;
Bossis, G ;
Brockly, F ;
Salvat, C ;
Jariel-Encontre, I ;
Piechaczyk, M .
BIOCHIMIE, 2001, 83 (3-4) :357-362
[3]  
Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO
[4]  
2-Z
[5]   THE ROLE OF JUN, FOS AND THE AP-1 COMPLEX IN CELL-PROLIFERATION AND TRANSFORMATION [J].
ANGEL, P ;
KARIN, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1072 (2-3) :129-157
[6]   Function and regulation of AP-1 subunits in skin physiology and pathology [J].
Angel, P ;
Szabowski, A ;
Schorpp-Kistner, M .
ONCOGENE, 2001, 20 (19) :2413-2423
[7]   Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression [J].
Bakiri, L ;
Lallemand, D ;
Bossy-Wetzel, E ;
Yaniv, M .
EMBO JOURNAL, 2000, 19 (09) :2056-2068
[8]   Promoter specificity and biological activity of tethered AP-1 dimers [J].
Bakiri, L ;
Matsuo, K ;
Wisniewska, M ;
Wagner, EF ;
Yaniv, M .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (13) :4952-4964
[9]   Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation [J].
Behrens, A ;
Jochum, W ;
Sibilia, M ;
Wagner, EF .
ONCOGENE, 2000, 19 (22) :2657-2663
[10]   Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice [J].
Bugge, TH ;
Lund, LR ;
Kombrinck, KK ;
Nielsen, BS ;
Holmbäck, K ;
Drew, AF ;
Flick, MJ ;
Witte, DP ;
Dano, K ;
Degen, JL .
ONCOGENE, 1998, 16 (24) :3097-3104